TP53 and malignant colon neoplasm: In another study, a specific DNA-PKcs inhibitor NU7441 radiosensitized TP53 wild type (LoVo) and TP53 mutant (SW620) colon cancer cell lines when applied at a non-cytotoxic dose and this effect was not significantly dependent on the TP53 status of cells.